Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 11:22 PM
Study NCT ID:
NCT02019693
Status:
COMPLETED
Last Update Posted:
2023-03-21
First Post:
2013-12-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01-24
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-17
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-20
First Submit QC Date:
None
Study First Post Date:
2013-12-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-12-09
Results First Submit QC Date:
None
Results First Post Date:
2023-03-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-20
Last Update Post Date:
2023-03-21
Last Update Post Date Type:
ACTUAL